Cell-Selex technology

BioResearch Open Access

Volumn 1, Issue 6, 2012, Pages 265-272

  Ohuchi, Shoji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

biomarkers; cancer research; nucleic acids; stem cells

Indexed keywords

MEMBRANE PROTEIN;

CELL SURFACE; COMBINATORIAL CHEMISTRY; DNA LIBRARY; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; REVIEW; TARGET CELL;

EID: 84983203127     PISSN: None     EISSN: 21647860     Source Type: Journal    
DOI: 10.1089/biores.2012.0253     Document Type: Review

References (52)

1. Klussmann S. The Aptamer Handbook: Functional Oligonucleotides and Their Applications. Wiley-VCH: Weinheim, 2006.
2. Stoltenburg R, Reinemann C, Strehlitz B. SELEX - a (r)evolutionary method to generate high-affinity nucleic acid ligands. Biomol Eng. 2007;24:381-403.
3. Ellington A, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature. 1990;346:818-822.
4. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 1990;249:505-510.
5. Vant-Hull B, Payano-Baez A, Davis RH, et al. The mathematics of SELEX against complex targets. J Mol Biol. 1998; 278:579-597.
6. Morris KN, Jensen KB, Julin CM, et al. High affinity ligands from in vitro selection: complex targets. Proc Natl Acad Sci USA. 1998;95:2902-2907.
7. Homann M, Goringer HU. Combinatorial selection of high affinity RNA ligands to live African trypanosomes. Nucleic Acids Res. 1999;27:2006-2014.
8. Lorger M, Engstler M, Homann M, et al. Targeting the variable surface of African trypanosomes with variant surface glycoprotein-specific, serum-stable RNA aptamers. Eukaryot Cell. 2003;2:84-94.
9. Ulrich H, Magdesian MH, Alves MJ, et al. In vitro selection of RNA aptamers that bind to cell adhesion receptors of Trypanosoma cruzi and inhibit cell invasion. J Biol Chem. 2002;277: 20756-20762.
10. Homann M, Goringer HU. Uptake and intracellular transport of RNAaptamers inAfrican trypanosomes suggest therapeutic ''piggy-back'' approach. Bioorg Med Chem. 2001;9:2571-2580.
11. Shangguan D, Li Y, Tang Z, et al. Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci USA. 2006;103:11838-11843.
12. Guo KT, Scha? fer R, Paul A, et al. Aptamer-based strategies for stem cell research. Mini Rev Med Chem. 2007;7: 701-705.
13. Tang Z, Parekh P, Turner P, et al. Generating aptamers for recognition of virus-infected cells. Clin Chem. 2009;55:813-822.
14. Blank M, Weinschenk T, Priemer M, et al. Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels. Selective targeting of endothelial regulatory protein pigpen. J Biol Chem. 2001;276:16464-16468.
15. Berezovski MV, Lechmann M, Musheev MU, et al. Aptamerfacilitated biomarker discovery (AptaBiD). J Am Chem Soc. 2008;130:9137-9143.
16. Cerchia L, Duconge F, Pestourie C, et al. Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase. PLoS Biol. 2005;3:e123.
17. Cerchia L, D'Alessio A, Amabile G, et al. An autocrine loop involving ret and glial cell-derived neurotrophic factor mediates retinoic acid-induced neuroblastoma cell differentiation. Mol Cancer Res. 2006;4:481-488.
18. Ohuchi SP, Ohtsu T, Nakamura Y. A novel method to generate aptamers against recombinant targets displayed on the cell surface. Nucl Acids Symp Ser. 2005;49:351-352.
19. Ohuchi SP, Ohtsu T, Nakamura Y. Selection of RNA aptamers against recombinant transforming growth factorbeta type III receptor displayed on cell surface. Biochimie. 2006;88:897-904.
20. RaddatzMS, Dolf A, Endl E, et al. Enrichment of cell-targeting and population-specific aptamers by fluorescence-activated cell sorting. Angew Chem Int Ed Engl. 2008;47:5190-5193.
21. Wu CC, Castro JE, Motta M, et al. Selection of oligonucleotide aptamers with enhanced uptake and activation of human leukemia B cells. Hum Gene Ther. 2003;14:849-860.
22. Mende M, Hopert A, Wu? nsche W, et al. A hexanucleotide selected for increased cellular uptake in cis contains a highly active CpG-motif in human B cells and primary peripheral blood mononuclear cells. Immunology. 2007;120: 261-272.
23. Mi J, Liu Y, Rabbani ZN, et al. In vivo selection of tumortargeting RNA motifs. Nat Chem Biol. 2010;6:22-24.
24. Chen F, Zhou J, Luo F, et al. Aptamer from whole-bacterium SELEX as new therapeutic reagent against virulent Mycobacterium tuberculosis. Biochem Biophys Res Commun. 2007;357: 743-748.
25. Joshi R, Janagama H, Dwivedi HP, et al. Selection, characterization, and application of DNA aptamers for the capture and detection of Salmonella enterica serovars. Mol Cell Probes. 2009;23:20-28.
26. Lee YJ, Han SR, Maeng JS, et al. In vitro selection of Escherichia coli O157:H7-specific RNA aptamer. Biochem Biophys Res Commun. 2012;417:414-420.
27. Li H, Ding X, Peng Z, et al. Aptamer selection for the detection of Escherichia coli K88. Can J Microbiol. 2011;57:453-459.
28. Cao X, Li S, Chen L, et al. Combining use of a panel of ssDNA aptamers in the detection of Staphylococcus aureus. Nucleic Acids Res. 2009;37:4621-4628.
29. Duan N, Wu S, Chen X, et al. Selection and identification of a DNA aptamer targeted to Vibrio parahemolyticus. J Agric Food Chem. 2012;60:4034-4038.
30. Dwivedi HP, Smiley RD, Jaykus LA. Selection and characterization of DNA aptamers with binding selectivity to Campylobacter jejuni using whole-cell SELEX. Appl Microbiol Biotechnol. 2010;87:2323-2334.
31. Hamula CL, Le XC, Li XF. DNA aptamers binding to multiple prevalent M-types of Streptococcus pyogenes. Anal Chem. 2011;83:3640-3647.
32. Zhang Y, Chen Y, Han D, et al. Aptamers selected 1 by cell- SELEX for application in cancer studies. Bioanalysis. 2010; 2:907-918.
33. Phillips JA, Lopez-Colon D, Zhu Z, et al. Applications of aptamers in cancer cell biology. Anal Chim Acta. 2008; 621:101-108.
34. Iwagawa T, Ohuchi SP, Watanabe S, et al. Selection of RNA aptamers against mouse embryonic stem cells. Biochimie. 2012;94:250-257.
35. Hopkins AL, Groom CR. The druggable genome. Nat Rev Drug Discov. 2002;1:727-730.
36. Rask-Andersen M, Almen MS, Schio? th HB. Trends in the exploitation of novel drug targets. Nat Rev Drug Discov. 2011;10:579-590.
37. Avci-Adali M, Metzger M, Perle N, et al. Pitfalls of cellsystematic evolution of ligands by exponential enrichment (SELEX): existing dead cells during in vitro selection anticipate the enrichment of specific aptamers. Oligonucleotides. 2010;20:317-323.
38. Zhang H, Torkamani A, Jones TM, et al. Phenotypeinformation- phenotype cycle for deconvolution of combinatorial antibody libraries selected against complex systems. Proc Natl Acad Sci USA. 2011;108:13456-13461.
39. Farokhzad OC, Jon S, Khademhosseini A, et al. Nanoparticleaptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Res. 2004;64:7668-7672.
40. Chu TC, Twu KY, Ellington AD, et al. Aptamer mediated siRNA delivery. Nucleic Acids Res. 2006;34:e73.
41. McNamara JO 2nd, Andrechek ER, Wang Y, et al. Cell typespecific delivery of siRNAs with aptamer-siRNA chimeras. Nat Biotechnol. 2006;24:1005-1015.
42. Kolesnikova O, Kazakova H, Comte C, et al. Selection of RNA aptamers imported into yeast and human mitochondria. RNA. 2010;16:926-941.
43. Douglas SM, Bachelet I, Church GM. A logic-gated nanorobot for targeted transport of molecular payloads. Science. 2012;335:831-834.
44. Smith JE, Medley CD, Tang Z, et al. Aptamer-conjugated nanoparticles for the collection and detection of multiple cancer cells. Anal Chem. 2007;79:3075-3082.
45. Herr JK, Smith JE, Medley CD, et al. Aptamer-conjugated nanoparticles for selective collection and detection of cancer cells. Anal Chem. 2006;78:2918-2924.
46. Scha? fer R, Wiskirchen J, Guo K, et al. Aptamer-based isolation and subsequent imaging of mesenchymal stem cells in ischemic myocard by magnetic resonance imaging. Rofo. 2007;179:1009-1015.
47. Nomura Y, Sugiyama S, Sakamoto T, et al. Conformational plasticity of RNA for target recognition as revealed by the 2.15 A° crystal structure of a human IgG-aptamer complex. Nucleic Acids Res. 2010;38:7822-7829.
48. Guo K, Wendel HP, Scheideler L, et al. Aptamer-based capture molecules as a novel coating strategy to promote cell adhesion. J Cell Mol Med. 2005;9:731-736.
49. Guo KT, Schafer R, Paul A, et al. A new technique for the isolation and surface immobilization of mesenchymal stem cells from whole bone marrow using high-specific DNAaptamers. Stem Cells. 2006;24:2220-2231.
50. Schroeder H, Ellinger B, Becker CF, et al. Generation of livecell microarrays by means of DNA-directed immobilization of specific cell surface ligands. Angew Chem Int Ed Engl. 2007;46:4180-4183.
51. Gartner ZJ, Bertozzi CR. Programmed assembly of 3-dimensional microtissues with defined cellular connectivity. Proc Natl Acad Sci USA. 2009;106:4606-4610.
52. Thiel KW, Hernandez LI, Dassie JP, et al. Delivery of chemosensitizing siRNAs to HER2 + -breast cancer cells using RNA aptamers. Nucleic Acids Res. 2012;40:6319-6337.